Apart from the global patentability requirements for inventions to have novelty, inventive step, and industrial applicability, the Indian patent act has specific provisions, covered under Section 3, that makes the patentability of an invention relating to subject matter such as a) derivatives of a pharmaceutical drug; b) patentability of stem cells; c) diagnostic methods and kits; d) isolated DNA sequences; e) computer-related inventions, etc. non-patentable subject matter.
As a result, these inventions face a higher threshold of examination and scrutiny. Though guidelines in relation to the patentability of software, biotech inventions, and pharmaceutical inventions have been issued by the Indian Patent Office, the practical challenges outlined below continue to be faced by patent holders.
The Insight IP Virtual Boardroom on ‘Patent Prosecution in India – Challenges & Opportunities’ is a perfect opportunity for you to gain expert insights on the particularities of the Indian market. This discussion – in which you can ask questions, gain opinions and learn from the experiences of others – will cover essential points to help shape your IP strategy in India.
Places are limited, so please register now!